SIGA Technologies Inc. SIGA 深 滬
交易中 08-08 10:54:15 美东时间
8.80
+0.250
+2.92%
華盛通- 最 高8.91
- 今 開8.56
- 成交量 15.99万股
- 最 低 8.50
- 昨 收 8.55
- 總市值 6.29亿
- 52周最高 10.17
- 市盈率 靜 10.69
- 換手率 0.00%
- 52周最低 4.35
- 委 比 29.87%
- 總股本 7144.11万
- 歷史最高 25.34
- 量 比 1.17
- 振 幅 4.80%
- 歷史最低 1.86
- 每 手 1
- 風險率 1.96%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多SIGA Technologies shares are trading higher after the company reported a year-over-year increase in Q2 financial results.
SIGA Technologies shares are trading higher after the company reported a year-o...
08-07 00:47
SIGA Technologies Q2 EPS $0.49 Up From $0.03 YoY, Sales $79.00M Up From $21.81M YoY
SIGA Technologies (NASDAQ:SIGA) reported quarterly earnings of $0.49 per share. This is a 1533.33 percent increase over earnings of $0.03 per share from the same period last year. The company reported $79.00 million in
08-06 04:04
Earnings Scheduled For August 5, 2025
Companies Reporting Before The Bell • Silicon Laboratories (NASDAQ:SLAB) is exp...
08-05 16:32
SIGA to Host Business Update Call on August 5, 2025 Following Release of Second-Quarter 2025 Results
SIGA Technologies announced that management will host a webcast and conference call on August 5, 2025, at 4:30 P.M. ET to provide a business update. Diem Nguyen, CEO, and Daniel Luckshire, CFO, will participate. The call can be accessed via webcast at http://www.siga.com or by dialing 1-800-717-1738 (domestic) or 1-646-307-1865 (international). A replay will be available for two weeks by dialing 1-844-512-2921 (domestic) or 1-412-317-6671 (intern...
07-29 11:30
Nanoviricides Announces That The Design Of The Adaptive Clinical Trial Protocol For Mpox Virus Clade Ia And Ib Infections And Disease Is Nearly Complete
The adaptive clinical trial is designed to provide information on three important aspects in a single, compact clinical trial:safe and effective dosing regimen in patients,safety and tolerability of the drug in patients,
07-14 18:32
Sigachi Industries Faces Tragic Incident at Telangana Facility
Sigachi Industries Limited ( ($IN:SIGACHI) ) has provided an announcement. Siga...
07-02 14:45
SIGA Technologies Q1 EPS $(0.01) Down From $0.14 YoY, Sales $7.04M Down From $25.43M YoY
SIGA Technologies (NASDAQ:SIGA) reported quarterly losses of $(0.01) per share. This is a 107.14 percent decrease over earnings of $0.14 per share from the same period last year. The company reported $7.04 million in
05-09 04:32
快讯 | SIGA公布截至2025年3月31日的三个月财务结果
SIGA Reports Financial Results for Three Months Ended March 31, 2025
05-09 04:05
NanoViricides Secures CNES Approval For NV-387 Phase II Clinical Trial In Democratic Republic Of Congo
NanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company") today reported that it has received approval from the National Ethics Committee for Health (CNES) of the Ministry of Public Health (MSP), of the Democratic Republic
05-08 18:39
Earnings Scheduled For May 8, 2025
Companies Reporting Before The Bell • Sempra (NYSE:SRE) is likely to report qua...
05-08 16:33
